Zentalis Pharmaceuticals ZNTL
NASDAQ ZNTL
$2.42 +0.03 (+1.26%)
As of: Oct 21, 2026 · 1:16 PM EDT

Zentalis Pharmaceuticals (ZNTL) Restructuring Costs (2025)

Updated

Zentalis Pharmaceuticals (ZNTL) recorded Restructuring Costs of $7.8 million in FY2025.

Analysis

Zentalis Pharmaceuticals (ZNTL) Restructuring Costs (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,134.96 Bn 1,103.55 Bn 19.71 Bn
2 Johnson & Johnson 616.51 Bn 535.04 Bn 17.26 Bn
3 AbbVie 501.10 Bn 474.21 Bn 12.70 Bn
4 Merck 367.09 Bn 321.47 Bn 12.21 Bn
5 Novartis Ag 298.10 Bn 262.09 Bn 11.24 Bn
6 Astrazeneca 261.72 Bn 235.40 Bn 12.86 Bn
7 Amgen 235.73 Bn 191.13 Bn 7.24 Bn
8 Gilead Sciences 190.64 Bn 164.84 Bn 6.22 Bn
9 Pfizer 169.63 Bn 116.28 Bn 10.94 Bn
10 Zentalis Pharmaceuticals 172.97 Mn -737.58 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 7.80 Mn
API Access

Zentalis Pharmaceuticals Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=ZNTL&period=max&api_key=YOUR_API_KEY